CDEK
← All trials

NCT05073003

Phase 1/Phase 2Interventional

Trials that are a combination of phases 1 and 2.

View on ClinicalTrials.gov ↗

Timeline

Start date
Oct 6, 2021
Primary completion
Apr 12, 2024
Completion date
Apr 20, 2024
First posted
Oct 11, 2021
Last posted
Nov 5, 2021
Enrollment
550
Arms / groups
20 / —
Source
AACT · ingestion pipeline

Sponsors

Drugs studied

Indications studied

CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.